Jump to content

Jean-François Borel

From Wikipedia, the free encyclopedia

Jean-François Borel(born 4 July 1933 inAntwerp,Belgium) is a Belgianmicrobiologistandimmunologistwho is considered one of the discoverers ofcyclosporin.

Early life[edit]

Borel studied at theUniversity of Antwerpand theETH Zurich,where he received his doctorate in immunological genetics in 1964. Afterwards he was at the Swiss Research Institute of Medicine. From 1970 he was in the research laboratories ofSandozinBasel.[1]

Discovery of cyclosporin[edit]

In 1972, Borel was involved in the discovery of theimmunosuppressiveeffects of cyclosporin (Sandoz called Sandimmun), which was isolated by Sandoz in 1971 from a fungus that a Sandoz employee brought back from vacation in Norway. The screening program at Sandoz was previously developed by K. Saameli (and Stähelin) and the immunological testing procedures of S. Lazary. Initially, use as an antibiotic was considered. When it was realized that the substance had onlyT-cellsand therefore had potential in transplantation medicine, Borel aroused much attention in 1976 at a congress in London. In the practice of organ transplantation, the new drug was tested in 1977 by the British surgeonRoy Yorke Calne.[2][3]

In 1983, Borel became vice president of the pharmaceutical division of Sandoz (laterNovartis). Since 1981 he was Professor of Immunopharmacology at theUniversity of Bern.

Also involved in the discovery and development wasHartmann Stähelin,head of the Pharmacology Department at Sandoz, which included the Immunology Department, and later there was a dispute over their respective shares in the discovery.[4][5][6][7]

Awards[edit]

See also[edit]

Organ transplantation

References[edit]

  1. ^"Jean-François BOREL".armb.be(in French). 20 June 2012.Retrieved7 August2018.
  2. ^Wermuth, Camille Georges (2011-05-02).The Practice of Medicinal Chemistry.Academic Press.ISBN9780080568775.
  3. ^Thompson, Larry (1988-11-15)."JEAN-FRANCOIS BOREL'S TRANSPLANTED DREAM".Washington Post.ISSN0190-8286.Retrieved2018-07-08.
  4. ^"Sandimmun-Streit: Novartis lässt Entdecker abklären".archiv.onlinereports.ch.Retrieved2018-07-08.
  5. ^Heusler, Karl (2001)."The controversial early history of cyclosporin".Swiss Medical Weekly.131(21–22): 299–302.doi:10.4414/smw.2001.09702.PMID11584691.S2CID24662504.
  6. ^Sherman, Irwin W. (2016-11-03).Drugs That Changed the World: How Therapeutic Agents Shaped Our Lives.CRC Press.ISBN9781315342641.
  7. ^Steiner, Rudolf (2012-01-24)."Wundermittel gegen die Abstossungsreaktion | NZZ".Neue Zürcher Zeitung(in Swiss High German).ISSN0376-6829.Retrieved2018-07-08.
  8. ^"Cloëtta Prize | Max Cloëtta Stiftung".cloetta-foundation.ch.Retrieved2018-07-08.
  9. ^"Jean-Francois Borel - Gairdner Foundation".Gairdner Foundation.Retrieved2018-07-08.
  10. ^"Goethe-Universität — Preisträger seit 1952".uni-frankfurt.de.Retrieved2018-07-08.